Scarica l'app Stockscreener
44.89
0.00%
0.0225
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AKRO Giù?
Forum
Previsione
Akero Therapeutics Inc Borsa (AKRO) Ultime notizie
Long-Term Shareholders Have Rights – If You Hold Akero Therapeutics, Inc. (NASDAQ: AKRO); ... - Bluefield Daily Telegraph
Long-Term Shareholders Have Rights – If You Hold Akero Therapeutics, Inc. (NASDAQ: AKRO); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); or Virtu Financial Inc. (NASDAQ: VIRT), Contact Grabar La - TradingView
Alkeon Capital Management LLC Sells 1,563,736 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
5AM Venture Management LLC Takes Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Renaissance Technologies LLC Invests $579,000 in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Sold by Schonfeld Strategic Advisors LLC - MarketBeat
Aquatic Capital Management LLC Buys 14,841 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Invesco Ltd. Purchases 21,086 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics (AKRO) Expected to Announce Quarterly Earnings on Friday - MarketBeat
T. Rowe Price Investment Management Inc. Decreases Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Foresite Capital Management VI LLC Makes New $10.15 Million Investment in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $256,437.50 in Stock - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Purchased by Price T Rowe Associates Inc. MD - MarketBeat
Brokerages Set Akero Therapeutics, Inc. (NASDAQ:AKRO) Target Price at $76.29 - Defense World
Tower Research Capital LLC TRC Has $450,000 Stake in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics (AKRO) Projected to Post Quarterly Earnings on Friday - Defense World
Analysts Set Akero Therapeutics, Inc. (NASDAQ:AKRO) Target Price at $76.29 - MarketBeat
Dark Forest Capital Management LP Buys Shares of 16,893 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Wells Fargo & Company MN Acquires 7,587 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
How does Akero Therapeutics Inc (AKRO) change from a tortoise to a hare? - Sete News
AKRO’s 2023 Market Dance: Up 63.95% – Time to Invest? - investchronicle.com
Emerald Mutual Fund Advisers Trust Lowers Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics (AKRO) Receives Buy Rating with Promising Pot - GuruFocus
Akero Therapeutics Inc (AKRO) receives a Buy rating from BofA Securities - knoxdaily.com
Jump Financial LLC Decreases Stake in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero (AKRO) Among Leading FGF21 Developers, Says Cantor Fitzgerald | AKRO Stock News - GuruFocus
Do investors need to be concerned about Akero Therapeutics Inc (AKRO)? - uspostnews.com
Akero Therapeutics Announces Upcoming Poster And Oral Presentations At The Easl Congress 2025 - marketscreener.com
Akero Therapeutics Announces Upcoming Poster and Oral Presentations at the EASL Congress 2025 - GlobeNewswire
Breakthrough: Akero's Efruxifermin Demonstrates Fibrosis Improvement in 96-Week MASH Trial - Stock Titan
(AKRO) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Quarterly Metrics: Quick and Current Ratios for Akero Therapeutics Inc (AKRO) - DWinneX
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Purchased by Barclays PLC - American Banking and Market News
Akero Therapeutics, Inc. (NASDAQ:AKRO) Position Increased by Invesco Ltd. - Defense World
Marshall Wace LLP Invests $7.65 Million in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Investor’s Delight: Akero Therapeutics Inc (AKRO) Closes Weak at 38.64, Down -4.55 - DWinneX
Akero Therapeutics, Inc. (NASDAQ:AKRO) Position Boosted by Wells Fargo & Company MN - Defense World
260,000 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Acquired by B Group Inc. - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock Holdings Lifted by Rock Springs Capital Management LP - MarketBeat
Akero Therapeutics Inc [AKRO] stock for 343,962 USD was sold by Yale Catriona - knoxdaily.com
AMRX Stock Sees Surge of Approximately 3.34% in Last Five Days - knoxdaily.com
Insider’s View: Deciphering Akero Therapeutics Inc (AKRO)’s Financial Health Through Ratios - DWinneX
Akero Therapeutics Inc (AKRO) looking to reclaim success with recent performance - Sete News
Akero Therapeutics Inc (AKRO) shows promising results - uspostnews.com
Walleye Capital LLC Takes $3.75 Million Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Akero Therapeutics, Inc. to - Bluefield Daily Telegraph
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Akero Therapeutics, Inc. to Contact Law Firm - TradingView
0.27%
0.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):